Korro Bio, Inc. (KRRO)
(Delayed Data from NSDQ)
$80.01 USD
+3.01 (3.91%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $80.08 +0.07 (0.09%) 7:20 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -2.60 |
EPS Last Quarter | -2.43 |
Last EPS Surprise | -1.25% |
ABR | 1.20 |
Earnings ESP
|
-7.44% |
---|---|
Current Year | -10.09 |
Next Year | -10.87 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.60 | -2.62 | -10.09 | -10.87 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -2.79 | -2.89 | -10.56 | -12.07 |
High Estimate | -2.40 | -2.45 | -9.72 | -10.17 |
Low Estimate | -2.79 | -2.89 | -10.56 | -12.07 |
Year ago EPS | NA | NA | -53.08 | -10.09 |
Year over Year Growth Est. | NA | NA | 80.99% | -7.70% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.60 | -2.62 | -10.09 | -10.87 |
7 Days Ago | -2.60 | -2.62 | -10.09 | -10.87 |
30 Days Ago | -2.60 | -2.62 | -10.09 | -10.87 |
60 Days Ago | -2.50 | -2.49 | -10.29 | -11.15 |
90 Days Ago | -2.34 | -2.47 | -9.64 | -10.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.79 | -2.89 | -10.56 | -12.07 |
Zacks Consensus Estimate | -2.60 | -2.62 | -10.09 | -10.87 |
Earnings ESP | -7.44% | -10.17% | -4.63% | -11.04% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.43 | -2.44 | NA | NA | NA |
Estimate | -2.40 | -2.36 | NA | NA | NA |
Difference | -0.03 | -0.08 | NA | NA | -0.06 |
Surprise | -1.25% | -3.39% | NA | NA | -2.32% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more